Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist
currently in Phase 3 clinical trials. Sold strictly for
research purposes only. Not for human consumption.
Each vial contains 15mg lyophilized powder. Requires
bacteriostatic water for reconstitution (sold separately).
For research purposes only.
Reviews
There are no reviews yet.